Home›Stock Screener›Entero Healthcare Solutions

Entero Healthcare Solutions Share Price Today | Stock Price & Entero Healthcare Solutions Share Screener

ENTERO Retail
Live Share Price NSE
₹1973.00
▼ -13.00 (-0.65%)
2026-11-19 00:00:00
Live Share Price BSE
₹1977.30
▼ -7.20 (-0.36%)
2026-11-19 00:00:00

As of November 19, 2026, the live Entero Healthcare Solutions share price (NSE: ENTERO) is ₹1,973.00 on NSE and ₹1,977.30 on BSE, down 0.65% from the previous close, with shares trading between ₹1,940.00 and ₹2,000.00 in today's trading session, and a 52-week range of ₹949.20–₹2,114.90. Track ENTERO market cap trends to gauge the company's total market size. Use the Entero Healthcare Solutions stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Entero Healthcare Solutions opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹2,091 and net income of ₹61, with EBITDA of ₹115, an operating margin of 5.0% and a profit margin of 2.9%.

Entero Healthcare Solutions Market Cap ₹8,559.25 Cr.
ENTERO P/E Ratio (TTM) 44.70
Entero Healthcare Solutions P/B Ratio 4.81
EPS (TTM) ₹26.44
Dividend Yield -
Debt to Equity 0.31
ENTERO 52 Week High ₹2114.90
Entero Healthcare Solutions 52 Week Low ₹949.20
Operating Margin 5.00%
Profit Margin 2.92%
ENTERO Revenue (TTM) ₹2,091.00
EBITDA ₹115.00
Net Income ₹61.00
Total Assets ₹3,600.00
Total Equity ₹1,753.00

Entero Healthcare Solutions Share Price Chart

Track the current stock price of Entero Healthcare Solutions with an interactive chart. Analyse ENTERO share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Entero Healthcare Solutions stock quote in one place.

The quote of ₹1,973.00 sits between the 52-week low of ₹949.20 and the 52-week high of ₹2,114.90, and the latest session moved -0.65% from the previous close.

Entero Healthcare Solutions Company Profile - Fundamental Screener

Screen Entero Healthcare Solutions company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ENTERO shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Consumer Services sector and the Retail industry, and it trades under ISIN INE010601016.

Company Details

Classification

Sector Consumer Services
Industry Retail
Sub-Sector Retail
Segment E

Identifiers and Leadership

ISIN INE010601016

Entero Healthcare Solutions Balance Sheet Screener

Screen ENTERO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹3,600, up from ₹2,703 in 2025.

Latest statistics put total assets at ₹3,600 and shareholder funds at ₹1,753, with a leverage ratio of 0.31.

Item 2026 2025 2024 2023 2022 2021 2020

Assets

Total Assets 3,600 2,703 2,345 1,309 1,126 836 749
Current Assets 0 0 0 0 0 0 0
Fixed Assets 958 559 289 268 262 189 186

Liabilities

Total Liabilities 0 0 0 0 0 0 0
Current Liabilities 260 87 102 87 101 58 56
Non-Current Liabilities 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 1,753 1,770 1,641 598 563 487 424
Share Capital 44 44 44 4 4 517 439
Reserves & Surplus 1,639 1,676 1,593 -73 -62 -32 -16

Entero Healthcare Solutions Income Statement Screener - Profit & Revenue Analysis

Screen Entero Healthcare Solutions income statement and profit fundamentals. Analyze ENTERO quarterly results. Entero Healthcare Solutions reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Sept, revenue was ₹2,091 and net profit was ₹61, equal to earnings per unit of ₹10.47, at an operating margin of 5%.

In that period expenses were ₹1,976, interest cost ₹23 and tax ₹18. The next period listed, 2026-Jun, shows revenue of ₹1,944 and net profit of ₹52.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar

Revenue and Expenses

Revenue 2,091 1,944 1,914 1,711 1,576 1,410 1,346 1,367 1,312 1,111 1,043 994 998 901 888
Expenses 1,976 1,844 1,824 1,647 1,509 1,354 1,290 1,309 1,258 1,067 1,005 964 968 873 867

Operating Costs and Margins

EBITDA 115 100 90 64 67 56 56 58 54 44 38 30 31 27 21
Operating Profit % 5.00% 5.00% 5.00% 3.00% 4.00% 4.00% 4.00% 4.00% 3.00% 3.00% 3.00% 3.00% 3.00% 3.00% 2.00%
Depreciation 13 12 15 10 10 9 9 8 8 7 7 6 6 6 7
Interest 23 21 17 14 12 11 11 10 12 10 17 16 18 14 13

Profit and Earnings

Profit Before Tax 78 67 58 40 45 36 37 39 35 27 14 8 7 7 1
Tax 18 15 13 7 8 6 6 10 9 7 -8 1 2 0 5
Net Profit 61 52 45 34 37 30 31 30 26 21 21 7 5 6 -4
EPS 10.47 8.77 6.44 6.35 7.26 6.39 5.91 5.85 5.43 4.62 5.73 4.21 3.24 15.18 1.49

Entero Healthcare Solutions Cash Flow Screener - Liquidity Fundamentals

Screen ENTERO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹96, and net cash flow was an outflow of ₹82.

Over the same period, investing activities used ₹302 and financing activities provided ₹124.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March

Cash from Operations and Investing

Operating Activities 96 -77 -37 -45 -35 -69 -37
Investing Activities -302 232 -704 -49 -162 -31 -203

Financing and Net Cash

Financing Activities 124 -74 863 73 211 89 217
Net Cash Flow -82 82 122 -21 14 -11 -23

Entero Healthcare Solutions Shareholding Pattern Screener

See Entero Healthcare Solutions shareholding pattern with promoter, FII, and DII holdings. Check Entero Healthcare Solutions promoter holding and ownership changes for ENTERO on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 52.42%, foreign institutions 4.03%, domestic institutions 16.62% and the public 12.25%, spread across 39,084 shareholders.

The shareholder count was 39,084 in 2026-Mar, compared with 39,710 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Feb

Promoter Holding

Promoter Holding 52.42% 52.40% 52.40% 52.42% 52.42% 52.42% 52.42% 52.44%

Institutional Investors

FII Holding 4.03% 4.37% 5.77% 19.92% 17.20% 14.67% 5.14% 0.00%
DII Holding 16.62% 15.48% 21.16% 9.64% 10.18% 9.65% 16.42% 1.36%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 12.25% 13.05% 13.14% 5.41% 6.99% 9.36% 11.56% 5.72%
Other Holding 14.68% 14.70% 7.53% 12.61% 13.20% 13.90% 14.46% 40.48%
Shareholder Count 39,084 39,710 40,919 33,159 33,338 36,334 40,333 58

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Entero Healthcare Solutions. Entero Healthcare Solutions dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Entero Healthcare Solutions.

Entero Healthcare Solutions Stock Index Membership - Nifty & Sensex

See which indices include Entero Healthcare Solutions stock. Check ENTERO index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 6 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE Consumer Discretionary Index, BSE INDEX SMLCAP, NIFTY IPO.

Complete Index List

BSE 1000
BSE Consumer Discretionary Index
BSE INDEX SMLCAP
NIFTY IPO
NIFTY MICROCAP250
NIFTY TOTAL MKT

Entero Healthcare Solutions Market Events Screener - Corporate Actions

Get Entero Healthcare Solutions corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Entero Healthcare Solutions stock events that may affect ENTERO share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 4, 2026, with a record date of November 4, 2026.

It is followed by Annual General Meeting dated August 19, 2026 and Quarterly Result Announcement dated August 7, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-04 2026-11-04 Quarterly Result Announcement NA 6.85%
2026-08-19 2026-08-19 Annual General Meeting NA 3.97%
2026-08-07 2026-08-07 Quarterly Result Announcement NA -2.43%
2026-05-25 2026-05-25 Quarterly Result Announcement NA 13.55%
2026-02-12 2026-02-12 Quarterly Result Announcement NA 1.49%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -2.01%
2025-09-18 2025-09-18 Annual General Meeting NA -2.28%
2025-08-08 2025-08-08 Quarterly Result Announcement NA -0.69%
2025-05-27 2025-05-27 Quarterly Result Announcement NA 2.33%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -3.18%
2024-11-12 2024-11-12 Quarterly Result Announcement NA 6.49%
2024-08-28 2024-08-28 Annual General Meeting NA 4.51%

Entero Healthcare Solutions Competitors Screener - Peer Stocks Comparison

Screen ENTERO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Consumer Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Eternal 361,936 727.20 55,760 161.54% 366 72.55
Avenue Supermarts DMart 226,329 72.30 68,895 15.82% 2,970 55.55
Trent 169,377 89.30 20,189 16.34% 1,721 64.34
Lenskart Solutions 128,543 160.40 8,988 28.23% 501 67.22
Meesho 116,877 -126.20 13,099 32.30% -1,358 66.69
Nykaa 102,542 316.20 10,055 26.05% 204 57.75
Info Edge 76,189 34.20 4,343 10.72% 1,763 43.03
Swiggy 52,032 -14.70 23,561 50.81% -4,154 38.88
Vishal Mega Mart 43,564 49.30 12,993 20.58% 839 47.18
Urban Company 24,926 -58.00 1,692 34.23% -235 52.83

Entero Healthcare Solutions Company Announcements - News & Reports Screener

Screen ENTERO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 15, 2026.

The next most recent announcements are dated November 6, 2026 and November 5, 2026.

Date Update Actions
2026-11-15 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-11-06 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-05 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-11-05 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-11-05 Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 -
2026-11-04 Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-11-04 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-11-04 Grant Of Fresh 49712 (Forty-Nine Thousand Seven Hundred Twelve) Employee Stock Options Under The Existing Entero Employee Stock Option Plan 2023. -
2026-11-04 Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30 2026 -
2026-11-04 Board Meeting Outcome for Outcome Of Board Meeting Held On November 04 2026 -
2026-10-28 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-10-22 Board Meeting Intimation for Consider Approve And Take On Record The Unaudited Standalone And Consolidated Financial Results (Along With Limited Review Report) For The Quarter Ended September 30 2026 -
2026-10-13 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-12 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS -
2026-09-23 Closure of Trading Window -
2026-09-22 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-22 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-09-12 Entero Healthcare Solutions Limited Has Informed The Exchange About General Updates -
2026-08-26 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-08-24 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹1,973.00, within a 52-week range of ₹949.20 to ₹2,114.90. The P/E ratio is 44.70 and the P/B ratio is 4.81, with earnings per unit of ₹26.44. Market capitalisation stands at ₹8,559.25 Cr. The company operates in the Consumer Services sector, in the Retail industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 20, 2026. This page covers 7 balance sheet periods, 15 income statement periods, 7 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.